Propensity-score Matched Comparison of Salvage Chemotherapy Regimens in Relapsed/Refractory Acute Myeloid Leukemia

CONCLUSION: This analysis supports the FLAG regimen as an effective and well-tolerated salvage therapy for patients with relapsed/refractory AML.PMID:33612433 | DOI:10.1016/j.clml.2021.01.011

Source: Clinical Lymphoma and Myeloma - February 22, 2021 Category: Cancer & Oncology Authors: Justin H Reid Bernard L Marini Lydia L Benitez Kristen Pettit Dale L Bixby Patrick Burke Anthony J Perissinotti Source Type: research